• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for June 23, 2025

June 23, 2025
Med-tech firms raising money in public or private financings, including: Archimedes Vascular.
Read More

In the clinic for June 23, 2025

June 23, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Fractyl Health, Irhythm, Medtronic.
Read More

Other news to note for June 23, 2025

June 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Ancora Heart, H.U. Group Holdings, Fujirebio Holdings, Fujirebio Diagnostics, Pharmasens, Sibionics, Tandem Diabetes, Thermo Fisher.
Read More

Regulatory actions for June 23, 2025

June 23, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Quanterix.
Read More

Med-tech gainers and losers for June 16-20, 2025

June 23, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Regulatory actions for June 23, 2025

June 23, 2025
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Bio-Thera, Cel-Sci, Cycle, Eisai, Eli Lilly, Excellthera, Exelixis, Gilead, GSK, Incyte, Ipsen, Johnson & Johnson, Madrigal, Merck, Orion, Regeneron, Relief, Sanofi, Springworks.
Read More

Other news to note for June 23, 2025

June 23, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abtherx, GPCR, Indivior, Neurocrine, Prothena.
Read More

In the clinic for June 23, 2025

June 23, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Capricor, Grifols, Zealand.
Read More

Financings for June 23, 2025

June 23, 2025
Biopharmas raising money in public or private financings, including: Aptose, Bausch + Lomb, Hanmi, Jyong, Moleculin, Paradigm, Pioneer, Quince.
Read More

Appointments and advancements for June 23, 2025

June 23, 2025
New hires and promotions in the biopharma industry, including: Annexon, Tharimmune, Tulavi.
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 1589 1590 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe